Impacto del bloqueo del sistema renina-angiotensina en el pronóstico del síndrome coronario agudo en función de la fracción de eyección
Sergio Raposeiras‐Roubín(University Hospital Complex Of Vigo), Andrés Íñiguez(University Hospital Complex Of Vigo), Yuji Ikari(Tokai University), Ioanna Xanthopoulou(General University Hospital of Patras), Michał Kowara, Christoph Liebetrau(Kerckhoff Klinik), Helge Möllmann(St.-Johannes-Hospital Dortmund), Albert Ariza‐Solé(Bellvitge University Hospital), Xiantao Song(Capital University), Fiorenzo Gaïta(Department of Medical Sciences), Stephen B. Wilton(Libin Cardiovascular Institute of Alberta), Neriman Osman(Kerckhoff Klinik), Borja Ibáñez(Spanish National Centre for Cardiovascular Research), Krzysztof J. Filipiak(Postgraduate School of Molecular Medicine), Berenice Caneiro‐Queija(University Hospital Complex Of Vigo), Fabrizio D’Ascenzo(University of Padua), Jingyao Fan(Capital Medical University), Takuya Nakahayshi(Kanazawa University), Tetsuma Kawaji(Mitsubishi Kyoto Hospital), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Wouter J. Kikkert, Yalei Chen(Pfizer (United States)), Iván J. Núñez‐Gil(Hospital Clínico San Carlos), Shaoping Nie(State Key Laboratory of Food Science and Technology), María Cespón‐Fernández(Universitair Ziekenhuis Brussel), Danielle A. Southern(Libin Cardiovascular Institute of Alberta), Isabel Muñoz‐Pousa(University Hospital Complex Of Vigo), Emad Abu‐Assi(University Hospital Complex Of Vigo), Belén Terol(Hospital Clínico San Carlos), Masa‐aki Kawashiri(Kanazawa University), Rafael Cobas-Paz(University Hospital Complex Of Vigo), Hiroki Shiomi(Kyoto University), Luis Correia(Hospital São Rafael), Francesca Giordana(University of Turin), Saško Kedev, Zenon Huczek(Medical University of Warsaw), Alberto Garay(Bellvitge University Hospital), Kenji Sakata(Kanazawa University), Oliver Kalpak(University Clinic of Traumatology), Yan Yan(Capital Medical University), Dongfeng Zhang(Beijing Anzhen Hospital), Xiao Wang(Beijing University of Chinese Medicine), Dimitrios Alexopoulos(General University Hospital of Patras), José Manuel García‐Ruiz(Spanish National Centre for Cardiovascular Research), Masakazu Yamagishi(Kanazawa University), Emilio Alfonso(Hospital Clínico San Carlos), Josè P.S. Henriques(University of Amsterdam), Jorge Saucedo, Toshiharu Fujii(Tokai University)
Cited by 10
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k